1. Rahman M, Awosika AO, Nguyen H. Valproic Acid. StatPearls. StatPearls Publishing; 2024.
2. Alqarni F, Eweis HS, Ali A, Alrafiah A, Alsieni M, Karim S, et al. The effect of coenzyme Q10 on liver injury induced by valproic acid and its antiepileptic activity in rats. Biomedicines 2022; 10: 168-188.
3. Sharma A, Sanchez J, Dew M, Shergill G. Valproate-associated transaminitis and rhabdomyolysis. Cureus 2023; 15: e38348-38351.
4. Kucey AS, Velenosi TJ, Tonial NC, Tieu A, RaoPeters AAE, Urquhart BL. The effect of chronic kidney disease on CYP2B expression and activity in male Wistar rats. Pharmacol Res Perspect 2019; 7: e00475-483.
5. Sekretarska J, Szczepaniak J, Sosnowska M, Grodzik M, Kutwin M, Wierzbicki M, et al. Influence of selected carbon nanostructures on the CYP2C9 enzyme of the P450 cytochrome. Materials (Basel) 2019; 12: 4149-4163.
6. Negishi M, Kobayashi K, Sakuma T, Sueyoshi T. Nuclear receptor phosphorylation in xenobiotic signal transduction. J Biol Chem 2020; 295: 15210-15225.
7. Rodrigues RM, De Kock J, Doktorova TY, Rogiers V, Vanhaecke T. Measurement of cytochrome P450 enzyme induction and inhibition in human hepatoma cells. Methods Mol Biol 2015; 1250: 279-285.
8. Idrees M, Xu L, El Sheikh M, Sidrat T, Song SH, Joo MD, et al. The PPARδ agonist GW501516 improves lipolytic/lipogenic balance through CPT1 and PEPCK during the development of pre-implantation bovine embryos. Int J Mol Sci 2019; 20: 6066-6084.
9. Yumuk VD. Targeting components of the stress system as potential therapies for the metabolic syndrome: the peroxisome-proliferator-activated receptors. Ann NY Acad Sci 2006; 1083: 306-318.
10. Suzuki M, Nakamura F, Taguchi E, Nakata M, Wada F, Takihi M, et al. 4’,6-Dimethoxyisoflavone-7-O-β-D-glucopyranoside (wistin) is a peroxisome proliferator-activated receptor α (PPARα) agonist in mouse hepatocytes. Mol Cell Biochem 2018; 446: 35-41.
11. Liu JJ, Dai XJ, Xu Y, Liu PQ, Zhang Y, Liu XD, et al. Inhibition of lymphoma cell proliferation by peroxisomal proliferator-activated receptor-γ ligands via wnt signaling pathway. Cell Biochem Biophys 2012; 62: 19-27.
12. Grygiel-Górniak B. Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications--A review. Nutr J 2014; 13: 17.
13. Wang Z, Yang K, Zheng Q, Zhang C, Tang H, Babicheva A, et al. Divergent changes of p53 in pulmonary arterial endothelial and smooth muscle cells involved in the development of pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2018; 316: L216-L228.
14. Ashkenazi A, Fairbrother WJ, Leverson JD, Souers AJ. From basic apoptosis discoveries to advanced selective bcl-2 family inhibitors. Nat Rev Drug Discov 2017; 16: 273-284.
15. Uxa S, Bernhart SH, Mages CFS, Fischer M, Kohler R, Hoffmann S, et al. DREAM and RB cooperate to induce gene repression and cell-cycle arrest in response to p53 activation. Nucleic Acids Res 2019; 47(17): 9087-9103.
16. Qiu XG, Chen YD, Yuan J, Zhang N, Lei T, Liu J, et al. Functional bcl-2 rs2279115 promoter noncoding variant contributes to glioma predisposition, especially in males. DNA Cell Biol 2019; 38: 85-90.
17. Shanmugam MK, Arfuso F, Kumar AP, Wang L, Goh BC, Ahn KS, et al. Modulation of diverse oncogenic transcription factors by thymoquinone, an essential oil compound isolated from the seeds of Nigella sativa Linn. Pharmacol Res 2018; 129: 357-364.
18. Darakhshan S, Pour AB, Colagar AH, Sisakhtnezhad S. Thymoquinone and its therapeutic potentials. Pharmacol Res 2015; 95-96: 138-158.
19. Samarghandian S, Farkhondeh T, Samini F. A review on possible therapeutic effect of Nigella sativa and thymoquinone in neurodegenerative diseases. CNS Neurol Disord Drug Targets 2018; 17: 412-420.
20. Taysi S, Algburi FS, Mohammed ZR, Ali OA, Taysi ME. Thymoquinone: A review on its pharmacological importance, and its association with oxidative stress, covid-19, and radiotherapy. Mini Rev Med Chem 2022; 22: 1847-1875.
21. Meydan S, Esrefoglu M, Selek S, Tosunoglu EA, Ozturk O, Kurbeti N, et al. Protective effects of caffeic acid phenethyl ester and thymoquinone on toluene induced liver toxicity. Biotech Histochem 2019; 94: 277-282.
22. Barrett CE, Hennessey TM, Gordon KM, Ryan SJ, McNair ML, Ressler KJ, et al. Developmental disruption of amygdala transcriptome and socioemotional behavior in rats exposed to valproic acid prenatally. Mol Autism 2017; 8: 42-59.
23. Atta MS, Almadaly EA, El-Far AH, Saleh RM, Assar DH, Al Jaouni SK, et al. Thymoquinone defeats diabetes-induced testicular damage in rats targeting antioxidant, inflammatory and aromatase expression. Int J Mol Sci 2017; 18: 919-934.
24. Aydın G, Adaleti R, Boz ES, Yücel FM, Özhan HK, Aksaray S. Investigation of anti-HCV S/CO value in detecting viremia in patients with Hepatitis C virus infection. Mikrobiyol Bul 2020; 54: 110-119.
25. Azırak S, Özgöçmen M. Linalool prevents kidney damage by inhibiting rifampicin-induced oxidative stress and apoptosis. Tissue Cell 2023; 82: 102097.
26. Rao X, Huang X, Zhou Z, Lin X. An improvement of the 2ˆ(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis. Biostat Bioinforma Biomath 2013; 3: 71-85.
27. Cardiff RD, Miller CH, Munn RJ. Manual hematoxylin and eosin staining of mouse tissue sections. Cold Spring Harb Protoc 2014; 2014: 655-658.
28. Savran M, Ascı H, Armagan İ, Erzurumlu Y, Azırak S, Kaya Ozer M, et al. Thymoquinone could be protective against valproic acid-induced testicular toxicity by antioxidant and anti-inflammatory mechanisms. Andrologia 2020; 52: e13623.
29. Gibson-Corley KN, Olivier AK, Meyerholz DK. Principles for valid histopathologic scoring in research. Vet Pathol 2013; 50: 1007-1015.
30. Pitetzis DA, Spilioti MG, Yovos JG, Yavropoulou MP. The effect of VPA on bone: From clinical studies to cell cultures-The molecular mechanisms revisited. Seizure 2017; 48: 36-43.
31. Nanau RM, Neuman MG. Adverse drug reactions induced by valproic acid. Clin Biochem 2013; 46: 1323-1338.
32. Ezhilarasan D, Mani U. Valproic acid induced liver injury: An insight into molecular toxicological mechanism. Environ Toxicol Pharmacol 2022; 95: 103967.
33. Sadek KM, Lebda MA, Abouzed TK, Nasr SM, El-Sayed Y. The molecular and biochemical insight view of lycopene in ameliorating tramadol-induced liver toxicity in a rat model: Implication of oxidative stress, apoptosis, and MAPK signaling pathways. Environ Sci Pollut Res Int 2018; 25: 33119-33130.
34. Zeweil MM, Sadek KM, Elsadek MF, Mahmoud SF, Ahmed BM, Khafaga AF. Sidr honey abrogates the oxidative stress and downregulates the hyaluronic acid concentration and gene expression of TGF-β1 and COL1a1 in rat model of thioacetamide-induced hepatic fibrosis. Anim Sci J 2020; 91: e13434.
35. Chang R, Chou MC, Hung LY, Wang ME, Hsu MC, Chiu CH. Study of valproic acid-enhanced hepatocyte steatosis. Biomed Res Int 2016; 2016: 9576503-9576514.
36. Verrotti A, la Torre R, Trotta D, Mohn A, Chiarelli F. Valproate-induced insulin resistance and obesity in children. Horm Res 2009; 71: 125-131.
37. Zhang H, Dong X, Zhu L, Tang F-S. Elafibranor: A promising treatment for alcoholic liver disease, metabolic-associated fatty liver disease, and cholestatic liver disease. World J Gastroenterol 2024; 30: 4393-4398.
38. Abdelkader NF, Elyamany M, Gad AM, Assaf N, Fawzy HM, Elesawy WH. Ellagic acid attenuates liver toxicity induced by valproic acid in rats. J Pharmacol Sci 2020; 143: 23-29.
39. Salahshoor MR, Roshankhah S, Jalili C. Antioxidative properties of Thymus vulgaris on liver rats induced by paclitaxel. Pharmacogn Res 2019; 11: 315-320.
40. Lebda MA, Sadek KM, Abouzed TK, Tohamy HG, El-Sayed YS. Melatonin mitigates thioacetamide-induced hepatic fibrosis via antioxidant activity and modulation of proinflammatory cytokines and fibrogenic genes. Life Sci 2018; 192: 136-143.
41. Fareed MM, Khalid H, Khalid S, Shityakov S. Deciphering molecular mechanisms of carbon tetrachloride-induced hepatotoxicity: A brief systematic review. Curr Mol Med 2024; 24: 1124-1134.
42. Martínez M-A, Ares I, Rodríguez J-L, Martínez M, Roura-Martínez D, Castellano V, et al. Pyrethroid insecticide lambda-cyhalothrin induces hepatic cytochrome P450 enzymes, oxidative stress and apoptosis in rats. Sci Total Environ 2018; 631-632: 1371-1382.
43. Bayrak BB, Yilmaz S, Cakmak NH, Yanardag R. The effects of edaravone, a free-radical scavenger in lung injury induced by valproic acid demonstrated via different biochemical parameters. J Biochem Mol Toxicol 2021; 35: e22847.
44. Allocati N, Masulli M, Di Ilio C, Federici L. Glutathione transferases: Substrates, inihibitors and pro-drugs in cancer and neurodegenerative diseases. Oncogenesis 2018; 7: 8-23.
45. Vasques-Monteiro IML, Fernandes-da-Silva A, Miranda CS, Silva-Veiga FM, Daleprane JB, Souza-Mello V. Anti-steatotic effects of PPAR-alpha and gamma involve gut-liver axis modulation in high-fat diet-fed mice. Mol Cell Endocrinol 2024; 585: 112177.
46. van Breda SGJ, Claessen SMH, van Herwijnen M, Theunissen DHJ, Jennen DGJ, de Kok TMCM, et al. Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology 2018; 393: 160-170.
47. Rodrigues RM, Branson S, De Boe V, Sachinidis A, Rogiers V, De Kock J, et al. In vitro assessment of drug-induced liver steatosis based on human dermal stem cell-derived hepatic cells. Arch Toxicol 2016; 90: 677-689.
48. Wan S, Xie X, Yang G, Feng F. Discovery of the toxicity-related quality markers and mechanisms of Zhi-Zi-Hou-Po decoction based on Chinmedomics combined with differentially absorbed components and network pharmacology. J Ethnopharmacol 2024; 320: 117408.
49. Woo CC, Loo SY, Gee V, Yap CW, Sethi G, Kumar AP, et al. Anticancer activity of thymoquinone in breast cancer cells: possible involvement of PPAR-γ pathway. Biochem Pharmacol 2011; 82: 464-475.
50. Sezen ŞC, Kucuk A, Özer A, Kılıç Y, Mardin B, Alkan M, et al. Assessment of the effects of levosimendan and thymoquinone on lung injury after myocardial ischemia reperfusion in rats. Drug Des Devel Ther 2018; 12: 1347-1352.
51. Song N, Boku S, Nakagawa S, Kato A, Toda H, Takamura N, et al. Mood stabilizers commonly restore staurosporine-induced increase of p53 expression and following decrease of Bcl-2 expression in SH-SY5Y cells. Prog Neuropsychopharmacol Biol Psychiatry 2012; 38: 183-189.
52. Ghoneim FM, Alrefai H, Elsamanoudy AZ, El-Khair SMA, Khalaf HA. The protective role of prenatal alpha lipoic acid supplementation against pancreatic oxidative damage in offspring of valproic acid-treated rats: Histological and molecular study. Biology (Basel) 2020; 9: 239-256.
53. Korkmaz DT, Azirak S, Bilgic S, Bayram D, Ozer MK. Thymoquinone reduced RIPK1-dependent apoptosis caused by valproic acid in rat brain. Ann Med Res 2021; 28: 2005-2011.
54. Wei Y, Bao R, Hu L, Geng Y, Chen X, Wen Y, et al. Ti(3)C(2)(MXene) nanosheets disrupt spermatogenesis in male mice mediated by the ATM/p53 signaling pathway. Biol Direct 2023; 18: 30-46.
55. Abu-Risha SE, Sokar SS, Elzorkany KE, Elsisi AE. Donepezil and quercetin alleviate valproate-induced testicular oxidative stress, inflammation and apoptosis: Imperative roles of AMPK/SIRT1/ PGC-1α and p38-MAPK/NF-κB/ IL-1β signaling cascades. Int Immunopharmacol 2024; 134: 112240.
56. Mondal J, Samadder A, Khuda-Bukhsh AR. Psorinum 6× triggers apoptosis signals in human lung cancer cells. J Integr Med 2016; 14: 143-153.
57. Rana AK, Saraswati SSK, Anang V, Singh A, Singh A, Verma C, et al. Butyrate induces oxidative burst mediated apoptosis via glucose-6-phosphate dehydrogenase (G6PDH) in macrophages during mycobacterial infection. Microbes Infect 2024; 26: 105271-105281.
58. Shojaedini M, Hemadi M, Saki G, Fakhredini F, Khodayar MJ, Khorsandi L. Thymoquinone effects on autophagy, apoptosis, and oxidative stress in cisplatin-induced testicular damage in mice. J Assist Reprod Genet 2024; 41: 1881-1891.
59. Tagliatti V, Descamps C, Lefèvre M, Colet J-M. Predicting valproate-induced liver injury using metabolomic analysis of ex ovo chick embryo allantoic fluid. Metabolites 2023; 13: 721-736.
60. Jamal M, Azam M, Simjee SU. Combination of metformin and sub-therapeutic dose of valproic acid prevent valproic acid-induced toxicity in animal model of epilepsy. Drug Chem Toxicol 2024; 47: 287-295.
61. Farghaly ME, Khowailed AA, Aboulhoda BE, Rashed LA, Gaber SS, Ashour H. Thymoquinone potentiated the anticancer effect of cisplatin on hepatic tumorigenesis by modulating tissue oxidative stress and endoplasmic GRP78/CHOP signaling. Nutr Cancer 2022; 74: 278-287.
)